With the new funding, the company anticipates progressing its ‘lead’ preclinical assets towards clinical development. Credit: CrizzyStudio / Shutterstock. Coave Therapeutics has raised €32m ($33m)
Pittcon 2025 in Boston will connect industry experts to combat the synthetic psychedelic threat, enhancing testing protocols and public health initiatives.
Elderberry juice rich in anthocyanins boosts glucose regulation and fat metabolism, with significant effects on gut microbiota in overweight adults.
The advance of H5N1 bird flu reminds us that novel pathogens remain a stubborn threat. Although a full-blown pandemic doesn’t appear imminent, the virus’s ability
The acceleration of artificial intelligence is arriving just in time for the biopharmaceutical industry. The global demand for innovative, effective treatments is growing faster than ever as
Research reveals sex-specific free-carnitine deficiency in women with cognitive impairment, linking mitochondrial metabolism to Alzheimer’s disease progression.
The trial is set to involve a minimum of 600 TRS subjects. Credit: Volha_R / Shutterstock. Newron Pharmaceuticals and Myung In Pharm have signed a
UltraMarathonRT® RT-qPCR Kit offers unmatched data reliability and sensitivity for gene expression studies, streamlining workflows and preserving RNA integrity.
These deals come amid a surge in ADC dealmaking across the pharmaceutical sector. Credit: izusek via Getty Images. Lonza’s subsidiary Synaffix has secured licensing agreements
In mechanobiology, cells’ forces have been considered fundamental to their enhanced function, including fast migration.